- Administration simplicity for HCPs and patients
- No dilutions required
- Less preperation time compared to current method of IV infusion
New convenient 30-second IV PUSH administration for TROGARZO® administered every 2 weeks.
TROGARZO® is used in combination with other antiretroviral(s). Every TROGARZO® vial contains 200 mg.
30s IV Push or
15 min infusion
AFTER INITIAL LOADING DOSE INFUSION,
* Dependant on insurance coverage.
‡ Study design and results: Open-label, non-randomized study in clinically stable patients while on TROGARZO®-containing ARV regimens for at least 3 months (N=9) and HIV-uninfected individuals (N=10). All subjects received TROGARZO® maintenance dose as IV infusion and IV Push, and pharmacokinetics (PK), safety, and efficacy were evaluated. Bioequivalence was demonstrated between IV infusion and IV Push methods of administration and IV Push over 30-seconds was safe and well tolerated.